Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8476
Invesco Dividend Achievers ETF
PFM
$807M
| $515K | ﹤0.01% |
+14,935
| New | +$546K |
|
8477
Xtrackers FTSE Developed ex US Multifactor ETF
DEEF
$56.6M
| $514K | ﹤0.01% |
20,212
+4,026
| +25% | +$112K |
|
8478
Essent Group
ESNT
$6.24B
| $514K | ﹤0.01% |
13,236
-32,462
| -71% | -$1.32M |
|
|
CHS
8479
CALL
DELISTED
Chicos FAS, Inc.
CHS
| $514K | ﹤0.01% |
103,400
+20,600
| +25% | +$104K |
|
|
AMRN
8480
CALL
Amarin Corp
AMRN
$296M
| $513K | ﹤0.01% |
17,210
-580
| -3% | -$25K |
|
8481
PUT
MaxLinear
MXL
$7.69B
| $513K | ﹤0.01% |
15,100
-16,600
| -52% | -$696K |
|
8482
Innovator US Equity Power Buffer ETF September
PSEP
$824M
| $513K | ﹤0.01% |
18,230
+10,505
| +136% | +$303K |
|
8483
CALL
Transmedics
TMDX
$3.06B
| $513K | ﹤0.01% |
16,300
+3,900
| +31% | +$104K |
|
|
CSGS
8484
DELISTED
CSG Systems International
CSGS
| $512K | ﹤0.01% |
8,583
-58,477
| -87% | -$3.54M |
|
|
FARO
8485
DELISTED
Faro Technologies
FARO
| $512K | ﹤0.01% |
16,625
+6,990
| +73% | +$256K |
|
8486
IES Holdings
IESC
$15.8B
| $512K | ﹤0.01% |
16,979
+11,267
| +197% | +$362K |
|
|
CAN
8487
PUT
Canaan Creative
CAN
$170M
| $511K | ﹤0.01% |
158,800
-236,200
| -60% | -$892K |
|
8488
CALL
Utz Brands
UTZ
$1.25B
| $511K | ﹤0.01% |
37,000
-10,100
| -21% | -$140K |
|
8489
PUT
Armstrong World Industries
AWI
$7.57B
| $510K | ﹤0.01% |
6,800
+4,000
| +143% | +$338K |
|
8490
BioAtla
BCAB
$5.1M
| $510K | ﹤0.01% |
3,578
+1,558
| +77% | +$248K |
|
|
CMBM
8491
CALL
DELISTED
Cambium Networks
CMBM
| $510K | ﹤0.01% |
34,800
-48,700
| -58% | -$767K |
|
8492
PUT
CEL-SCI Corp
CVM
$27.1M
| $510K | ﹤0.01% |
3,780
-2,233
| -37% | -$233K |
|
8493
DHI Group
DHX
$185M
| $510K | ﹤0.01% |
102,628
-10,879
| -10% | -$64.6K |
|
8494
iShares Currency Hedged MSCI Emerging Markets
HEEM
$294M
| $510K | ﹤0.01% |
+19,939
| New | +$522K |
|
8495
CALL
Newmark Group
NMRK
$2.74B
| $510K | ﹤0.01% |
52,700
+24,500
| +87% | +$284K |
|
|
AMTI
8496
CALL
DELISTED
Applied Molecular Transport Inc. Common Stock
AMTI
| $510K | ﹤0.01% |
175,100
+103,000
| +143% | +$433K |
|
8497
Arcos Dorados Holdings
ARCO
$1.66B
| $509K | ﹤0.01% |
75,506
-11,927
| -14% | -$88.1K |
|
8498
Ecovyst
ECVT
$1.14B
| $509K | ﹤0.01% |
51,715
-117,294
| -69% | -$1.22M |
|
8499
PUT
OGE Energy
OGE
$9.78B
| $509K | ﹤0.01% |
+13,200
| New | +$525K |
|
|
KEEL
8500
PUT
Keel Infrastructure Corp
KEEL
$2.33B
| $508K | ﹤0.01% |
453,300
-268,400
| -37% | -$609K |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.